Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:1252-1259, 2006
DOI: 10.2337/db05-1554
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Starkey, J. M.
Right arrow Articles by Tilton, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Starkey, J. M.
Right arrow Articles by Tilton, R. G.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes-Induced Activation of Canonical and Noncanonical Nuclear Factor-{kappa}B Pathways in Renal Cortex

Jonathan M. Starkey1, Sigmund J. Haidacher1, Wanda S. LeJeune1, Xiaoquan Zhang1, Brian C. Tieu1,2, Sanjeev Choudhary1, Allan R. Brasier1,2,3, Larry A. Denner1,4, and Ronald G. Tilton1,4

1 Division of Endocrinology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas
2 Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas
3 Sealy Center for Molecular Sciences, University of Texas Medical Branch, Galveston, Texas
4 Stark Diabetes Center, University of Texas Medical Branch, Galveston, Texas

Address correspondence and reprint requests to Ronald G. Tilton, PhD, Division of Endocrinology, Department of Internal Medicine, Stark Diabetes Center, 8.138 Medical Research Building, University of Texas Medical Branch, 301 University Blvd., Galveston, TX 77555-1060. E-mail: rgtilton{at}utmb.edu

Abbreviations: DTT, dithiothreitol; EMSA, electrophoretic mobility shift assay; I{kappa}B, inhibitor of {kappa}B; IKK, inhibitor of {kappa}B kinase; IL, interleukin; NF-kB, nuclear factor-{kappa}B; NIK, NF-{kappa}B–inducing kinase; TNF, tumor necrosis factor

Evidence of diabetes-induced nuclear factor-{kappa}B (NF-{kappa}B) activation has been provided with DNA binding assays or nuclear localization with immunohistochemistry, but few studies have explored mechanisms involved. We examined effects of diabetes on proteins comprising NF-{kappa}B canonical and noncanonical activation pathways in the renal cortex of diabetic mice. Plasma concentrations of NF-{kappa}B–regulated cytokines were increased after 1 month of hyperglycemia, but most returned to control levels or lower by 3 months, when the same cytokines were increased significantly in renal cortex. Cytosolic content of NF-{kappa}B canonical pathway proteins did not differ between experimental groups after 3 months of diabetes, while NF-{kappa}B noncanonical pathway proteins were affected, including increased phosphorylation of inhibitor of {kappa}B kinase-{alpha} and several fold increases in NF-{kappa}B–inducing kinase and RelB, which were predominantly located in tubular epithelial cells. Nuclear content of all NF-{kappa}B pathway proteins was decreased by diabetes, with the largest change in RelB and p50 (approximately twofold decrease). Despite this decrease, measurable increases in protein binding to DNA in diabetic versus control nuclear extracts were observed with electrophoretic mobility shift assay. These results provide evidence for chronic NF-{kappa}B activation in the renal cortex of db/db mice and suggest a novel, diabetes-linked mechanism involving both canonical and noncanonical NF-{kappa}B pathway proteins.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
H.-Y. Lin, C.-L. Wang, P.-J. Hsiao, Y.-C. Lu, S.-Y. Chen, K.-D. Lin, S.-C. Hsin, M.-C. Hsieh, and S.-J. Shin
SUMO4 M55V Variant Is Associated With Diabetic Nephropathy in Type 2 Diabetes
Diabetes, April 1, 2007; 56(4): 1177 - 1180.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.